How much would you save
switching to OPTML?

Pick what you’re currently paying. We’ll show you the annual delta vs OPTML pricing, using the same active ingredients, prescribed by U.S.-licensed physicians.

Your current setup

Defaults to public listed retail rates from each provider.

You’d save
$0
Pick a protocol and source above.
Switch to OPTML →

How we calculate

We compare your current monthly spend (or the public listed price at the source you select) against OPTML’s annual-tier price for the same protocol. Annual savings = (current monthly − OPTML annual-tier monthly) × 12.

Compounded preparations use active pharmaceutical ingredients (semaglutide, tirzepatide, testosterone cypionate, estradiol, etc.) that are chemically identical to those used in the corresponding FDA-approved branded products. Compounded preparations are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. They are prepared by licensed 503A pharmacies under USP <797> sterility standards.

Source pricing is approximate and reflects publicly listed retail rates as of 2026. Verify directly on each provider’s website. This calculator is an estimation tool, not a quote.

Educational purposes only. The Savings Calculator provides educational estimates based on published clinical formulas and peer-reviewed research. It is not medical advice, does not constitute a prescription, and is not a substitute for evaluation by a licensed clinician. All medical decisions, including any treatment, medication, or dosing recommendations, are made exclusively by a U.S. licensed physician after individual patient evaluation through OPTML's intake process.
Methodology & Sources Click here for the formulas, datasets, and peer-reviewed studies behind this tool View details ↓Hide ↑

How this tool calculates

Savings estimates are based on the difference between publicly listed retail prices of FDA-approved branded medications and OPTML's flat compounded-medication subscription prices over a 12-month period. Retail prices are sourced from manufacturer disclosures and major pharmacy retail rates and change over time.

Peer-reviewed sources

  1. 1.Novo Nordisk. Wegovy List Price Disclosure. novonordisk.com.
  2. 2.Eli Lilly. Zepbound List Price Disclosure. lilly.com.
  3. 3.Goldman DP, Joyce GF, Zheng Y. Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health. JAMA. 2007;298(1):61-69.

Important. This tool is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The tool does not prescribe medication, recommend specific dosing, or substitute for clinical evaluation. Compounded medications referenced anywhere on this site are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Treatment decisions are made only by a licensed U.S. physician after individual patient evaluation.